Molecular diagnostics for infectious diseases involves the detection and analysis of microbial genetic material, such as DNA or RNA, to identify and diagnose infections. This advanced diagnostic approach uses techniques like polymerase chain reaction (PCR), nucleic acid amplification, and gene sequencing to detect the specific genetic signatures of pathogens. Molecular diagnostic tests offer high sensitivity and specificity, enabling the rapid and accurate identification of infectious agents, including bacteria, viruses, fungi, and parasites. These tests play a crucial role in disease diagnosis, monitoring treatment efficacy, and guiding appropriate therapeutic interventions, contributing to more targeted and personalized patient care.
The global Molecular Diagnostics for Infectious Diseases market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the 鈥淢olecular Diagnostics for Infectious Diseases Industry Forecast鈥� looks at past sales and reviews total world Molecular Diagnostics for Infectious Diseases sales in 2023, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostics for Infectious Diseases sales for 2024 through 2030. With Molecular Diagnostics for Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostics for Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostics for Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Diagnostics for Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Molecular Diagnostics for Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostics for Infectious Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostics for Infectious Diseases.
The market for molecular diagnostics in infectious diseases is characterized by rapid technological advancements and a growing emphasis on accurate and timely disease detection. Molecular diagnostics involve the identification of pathogens at the molecular level, enabling quicker and more precise diagnosis of infectious diseases. Factors such as the increasing incidence of infectious diseases, demand for point-of-care testing, and advancements in genomics contribute to the market's expansion. Key players in the industry focus on developing innovative diagnostic platforms and expanding their product portfolios to meet the rising demand for molecular diagnostic solutions. The market is anticipated to experience continuous growth as molecular diagnostics become integral in managing infectious diseases globally, offering benefits such as early detection, personalized treatment strategies, and monitoring of treatment effectiveness.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics for Infectious Diseases market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Respiratory Tract Infections
Reproductive Tract Infections
Blood-borne Infections (BBIs)
Gastrointestinal Infections (GIIs)
Other Infections
Segmentation by application
Hospital
Diagnostic Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Illumina
Qiagen
Abbott Laboratories
叠颈辞惭茅谤颈别耻虫
Cepheid (Danaher)
Thermo Fisher Scientific
Hologic
DiaSorin
Luminex
Hoffmann-La Roche
Biocartis
Nanomix
BioFire Diagnostics
Seegene
QuidelOrtho
ZeptoMetrix
Sansure
BGI Genomics
DaAn Gene
Kehua Bio-engineering
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molecular Diagnostics for Infectious Diseases market?
What factors are driving Molecular Diagnostics for Infectious Diseases market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Diagnostics for Infectious Diseases market opportunities vary by end market size?
How does Molecular Diagnostics for Infectious Diseases break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Molecular Diagnostics for Infectious Diseases by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Molecular Diagnostics for Infectious Diseases by Country/Region, 2019, 2023 & 2030
2.2 Molecular Diagnostics for Infectious Diseases Segment by Type
2.2.1 Respiratory Tract Infections
2.2.2 Reproductive Tract Infections
2.2.3 Blood-borne Infections (BBIs)
2.2.4 Gastrointestinal Infections (GIIs)
2.2.5 Other Infections
2.3 Molecular Diagnostics for Infectious Diseases Sales by Type
2.3.1 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Type (2019-2024)
2.3.2 Global Molecular Diagnostics for Infectious Diseases Revenue and Market Share by Type (2019-2024)
2.3.3 Global Molecular Diagnostics for Infectious Diseases Sale Price by Type (2019-2024)
2.4 Molecular Diagnostics for Infectious Diseases Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Laboratories
2.5 Molecular Diagnostics for Infectious Diseases Sales by Application
2.5.1 Global Molecular Diagnostics for Infectious Diseases Sale Market Share by Application (2019-2024)
2.5.2 Global Molecular Diagnostics for Infectious Diseases Revenue and Market Share by Application (2019-2024)
2.5.3 Global Molecular Diagnostics for Infectious Diseases Sale Price by Application (2019-2024)
3 Global Molecular Diagnostics for Infectious Diseases by Company
3.1 Global Molecular Diagnostics for Infectious Diseases Breakdown Data by Company
3.1.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales by Company (2019-2024)
3.1.2 Global Molecular Diagnostics for Infectious Diseases Sales Market Share by Company (2019-2024)
3.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue by Company (2019-2024)
3.2.1 Global Molecular Diagnostics for Infectious Diseases Revenue by Company (2019-2024)
3.2.2 Global Molecular Diagnostics for Infectious Diseases Revenue Market Share by Company (2019-2024)
3.3 Global Molecular Diagnostics for Infectious Diseases Sale Price by Company
3.4 Key Manufacturers Molecular Diagnostics for Infectious Diseases Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Diagnostics for Infectious Diseases Product Location Distribution
3.4.2 Players Molecular Diagnostics for Infectious Diseases Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Molecular Diagnostics for Infectious Diseases by Geographic Region
4.1 World Historic Molecular Diagnostics for Infectious Diseases Market Size by Geographic Region (2019-2024)
4.1.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Molecular Diagnostics for Infectious Diseases Market Size by Country/Region (2019-2024)
4.2.1 Global Molecular Diagnostics for Infectious Diseases Annual Sales by Country/Region (2019-2024)
4.2.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue by Country/Region (2019-2024)
4.3 Americas Molecular Diagnostics for Infectious Diseases Sales Growth
4.4 APAC Molecular Diagnostics for Infectious Diseases Sales Growth
4.5 Europe Molecular Diagnostics for Infectious Diseases Sales Growth
4.6 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Growth
5 Americas
5.1 Americas Molecular Diagnostics for Infectious Diseases Sales by Country
5.1.1 Americas Molecular Diagnostics for Infectious Diseases Sales by Country (2019-2024)
5.1.2 Americas Molecular Diagnostics for Infectious Diseases Revenue by Country (2019-2024)
5.2 Americas Molecular Diagnostics for Infectious Diseases Sales by Type
5.3 Americas Molecular Diagnostics for Infectious Diseases Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics for Infectious Diseases Sales by Region
6.1.1 APAC Molecular Diagnostics for Infectious Diseases Sales by Region (2019-2024)
6.1.2 APAC Molecular Diagnostics for Infectious Diseases Revenue by Region (2019-2024)
6.2 APAC Molecular Diagnostics for Infectious Diseases Sales by Type
6.3 APAC Molecular Diagnostics for Infectious Diseases Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Molecular Diagnostics for Infectious Diseases by Country
7.1.1 Europe Molecular Diagnostics for Infectious Diseases Sales by Country (2019-2024)
7.1.2 Europe Molecular Diagnostics for Infectious Diseases Revenue by Country (2019-2024)
7.2 Europe Molecular Diagnostics for Infectious Diseases Sales by Type
7.3 Europe Molecular Diagnostics for Infectious Diseases Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Diagnostics for Infectious Diseases by Country
8.1.1 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Country (2019-2024)
8.1.2 Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue by Country (2019-2024)
8.2 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Type
8.3 Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Diagnostics for Infectious Diseases
10.3 Manufacturing Process Analysis of Molecular Diagnostics for Infectious Diseases
10.4 Industry Chain Structure of Molecular Diagnostics for Infectious Diseases
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Diagnostics for Infectious Diseases Distributors
11.3 Molecular Diagnostics for Infectious Diseases Customer
12 World Forecast Review for Molecular Diagnostics for Infectious Diseases by Geographic Region
12.1 Global Molecular Diagnostics for Infectious Diseases Market Size Forecast by Region
12.1.1 Global Molecular Diagnostics for Infectious Diseases Forecast by Region (2025-2030)
12.1.2 Global Molecular Diagnostics for Infectious Diseases Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Molecular Diagnostics for Infectious Diseases Forecast by Type
12.7 Global Molecular Diagnostics for Infectious Diseases Forecast by Application
13 Key Players Analysis
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.1.3 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Illumina
13.2.1 Illumina Company Information
13.2.2 Illumina Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.2.3 Illumina Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Illumina Main Business Overview
13.2.5 Illumina Latest Developments
13.3 Qiagen
13.3.1 Qiagen Company Information
13.3.2 Qiagen Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.3.3 Qiagen Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Qiagen Main Business Overview
13.3.5 Qiagen Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.4.3 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 叠颈辞惭茅谤颈别耻虫
13.5.1 叠颈辞惭茅谤颈别耻虫 Company Information
13.5.2 叠颈辞惭茅谤颈别耻虫 Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.5.3 叠颈辞惭茅谤颈别耻虫 Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 叠颈辞惭茅谤颈别耻虫 Main Business Overview
13.5.5 叠颈辞惭茅谤颈别耻虫 Latest Developments
13.6 Cepheid (Danaher)
13.6.1 Cepheid (Danaher) Company Information
13.6.2 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.6.3 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Cepheid (Danaher) Main Business Overview
13.6.5 Cepheid (Danaher) Latest Developments
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Information
13.7.2 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.7.3 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Thermo Fisher Scientific Main Business Overview
13.7.5 Thermo Fisher Scientific Latest Developments
13.8 Hologic
13.8.1 Hologic Company Information
13.8.2 Hologic Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.8.3 Hologic Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hologic Main Business Overview
13.8.5 Hologic Latest Developments
13.9 DiaSorin
13.9.1 DiaSorin Company Information
13.9.2 DiaSorin Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.9.3 DiaSorin Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 DiaSorin Main Business Overview
13.9.5 DiaSorin Latest Developments
13.10 Luminex
13.10.1 Luminex Company Information
13.10.2 Luminex Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.10.3 Luminex Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Luminex Main Business Overview
13.10.5 Luminex Latest Developments
13.11 Hoffmann-La Roche
13.11.1 Hoffmann-La Roche Company Information
13.11.2 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.11.3 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hoffmann-La Roche Main Business Overview
13.11.5 Hoffmann-La Roche Latest Developments
13.12 Biocartis
13.12.1 Biocartis Company Information
13.12.2 Biocartis Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.12.3 Biocartis Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Biocartis Main Business Overview
13.12.5 Biocartis Latest Developments
13.13 Nanomix
13.13.1 Nanomix Company Information
13.13.2 Nanomix Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.13.3 Nanomix Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Nanomix Main Business Overview
13.13.5 Nanomix Latest Developments
13.14 BioFire Diagnostics
13.14.1 BioFire Diagnostics Company Information
13.14.2 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.14.3 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 BioFire Diagnostics Main Business Overview
13.14.5 BioFire Diagnostics Latest Developments
13.15 Seegene
13.15.1 Seegene Company Information
13.15.2 Seegene Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.15.3 Seegene Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Seegene Main Business Overview
13.15.5 Seegene Latest Developments
13.16 QuidelOrtho
13.16.1 QuidelOrtho Company Information
13.16.2 QuidelOrtho Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.16.3 QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 QuidelOrtho Main Business Overview
13.16.5 QuidelOrtho Latest Developments
13.17 ZeptoMetrix
13.17.1 ZeptoMetrix Company Information
13.17.2 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.17.3 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 ZeptoMetrix Main Business Overview
13.17.5 ZeptoMetrix Latest Developments
13.18 Sansure
13.18.1 Sansure Company Information
13.18.2 Sansure Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.18.3 Sansure Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Sansure Main Business Overview
13.18.5 Sansure Latest Developments
13.19 BGI Genomics
13.19.1 BGI Genomics Company Information
13.19.2 BGI Genomics Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.19.3 BGI Genomics Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 BGI Genomics Main Business Overview
13.19.5 BGI Genomics Latest Developments
13.20 DaAn Gene
13.20.1 DaAn Gene Company Information
13.20.2 DaAn Gene Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.20.3 DaAn Gene Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 DaAn Gene Main Business Overview
13.20.5 DaAn Gene Latest Developments
13.21 Kehua Bio-engineering
13.21.1 Kehua Bio-engineering Company Information
13.21.2 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Product Portfolios and Specifications
13.21.3 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Kehua Bio-engineering Main Business Overview
13.21.5 Kehua Bio-engineering Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
